Inpatient Bipolar Disorder Treatment at Amber Behavioral Health

Residential treatment for Bipolar disorder at Amber Behavioral Health helps men and women diagnosed with manic-depressive illness or bipolar disorder. We provide a wide range of treatment services for bipolar disorder, offering structured support that helps patients prepare for ongoing outpatient care & support. 

What is Bipolar Disorder?

Bipolar disorder, formerly known as manic-depressive illness, is a serious and chronic mood disorder characterized by extreme swings between emotional highs and lows. These swings are not simply changes in mood; they are distinct episodes of mania or hypomania and depression that significantly disrupt a person’s thinking, energy, behavior, and ability to function in daily life. [1, 2] Episodes can last days, weeks, or months, and they can occur with or without periods of stable mood in between.

Bipolar disorder is classified within the DSM-5 as part of the bipolar and related disorders spectrum, which sits between depressive disorders and schizophrenia spectrum disorders. [1] The aggregate lifetime prevalence of the bipolar spectrum, including bipolar I, bipolar II, and subthreshold bipolar, is approximately 2.4% globally. [3] The disorder typically emerges in the early-to-mid 20s, often following a long prodrome that may begin in adolescence, and it affects men and women in roughly equal numbers. [3, 4]

Bipolar disorder is one of the leading causes of disability worldwide. The suicide rate among individuals with bipolar disorder is estimated to be 10 to 30 times higher than that of the general population, making early diagnosis and sustained treatment critically important. [1]

Bipolar Disorder Causes and Risk Factors

Bipolar disorder does not have a single identifiable cause. Research consistently supports a biopsychosocial model in which genetic vulnerability, neurobiological factors, and environmental experiences interact to produce the disorder. [3, 5]

Genetic Factors:

  • Bipolar disorder is one of the most heritable psychiatric conditions. Twin studies estimate heritability at 60% to 85%, meaning that genetic factors account for a substantial portion of individual risk. [5, 6]
  • First-degree relatives of someone with bipolar disorder carry approximately 10 times the average risk of developing the condition themselves. [4]
  • If one identical twin is diagnosed, the other has a 40% to 70% chance of also developing bipolar disorder, underscoring that genetics is a major but not sole determinant. [6]
  • Key genetic associations have been found in genes involving calcium channel signaling (CACNA1C), brain-derived neurotrophic factor (BDNF), and dopamine pathways, though the genetic architecture is complex and polygenic. [5, 7]

 

Neurobiological Factors:

  • Dysregulation of neurotransmitter systems, including dopamine, serotonin, and norepinephrine, is well-documented in bipolar disorder and underlies both manic and depressive episodes. [7]
  • Abnormalities in HPA axis functioning, circadian rhythm regulation, and inflammatory processes are also associated with the disorder and may influence episode cycling. [7, 8]
  • Neuroimaging studies have identified structural and functional differences in regions including the prefrontal cortex, amygdala, and hippocampus in people with bipolar disorder. [7]

 

Environmental & Trauma-Related Factors:

  • Childhood trauma, including physical, sexual, and emotional abuse, is a documented risk factor for bipolar disorder and is associated with earlier onset, more severe symptoms, higher rates of rapid cycling, and greater suicide risk. [8, 9]
  • Environmental stressors such as major life events, disrupted sleep, substance use, and chronic psychosocial stress can trigger mood episodes in genetically predisposed individuals. [3, 9]
  • Perinatal factors including maternal infections during pregnancy, birth complications, and early-life adversity are also recognized risk contributors. [3]
  • Cannabis use during adolescence has been identified as a specific environmental risk factor for earlier onset and more severe presentations. [3]

Signs and Symptoms of Bipolar Disorder

Bipolar disorder presents through two primary types of mood episodes: manic (or hypomanic) and depressive. The pattern, duration, and severity of these episodes determine the specific diagnosis. Between episodes, many people with bipolar disorder function normally, though residual symptoms and cognitive effects are common. [1, 2]

Symptoms of a Manic Episode (required for Bipolar I):

  • Abnormally elevated, expansive, or irritable mood lasting at least one week, present most of the day, nearly every day
  • Markedly increased goal-directed activity or energy
  • Grandiosity or inflated self-esteem
  • Significantly decreased need for sleep without feeling tired
  • Racing thoughts or rapid, pressured speech
  • Distractibility and difficulty concentrating
  • Impulsive or reckless behavior with high potential for harmful consequences, such as unrestrained spending, sexual indiscretion, or poor business decisions [1]

 

Symptoms of Hypomania (present in Bipolar II; similar to mania but less severe and lasting at least 4 days):

  • Elevated or irritable mood with increased energy that is noticeable to others
  • Similar symptom profile to mania but without psychosis and without causing marked impairment
  • Often described as feeling unusually productive, creative, or energized; individuals may not perceive it as a problem

 

Symptoms of a Depressive Episode:

  • Persistent sadness, emptiness, or hopelessness
  • Loss of interest or pleasure in activities previously enjoyed (anhedonia)
  • Fatigue and significantly reduced energy
  • Changes in sleep: insomnia or hypersomnia
  • Cognitive difficulties: poor concentration, indecisiveness, slowed thinking
  • Feelings of worthlessness or excessive guilt
  • Recurrent thoughts of death or suicidal ideation [1, 2]

 

One of the most clinically significant early recognition challenges is that bipolar disorder frequently presents first as depression. Because the hypomanic or manic history may be absent, brief, or unrecognized, clinicians must specifically inquire about past episodes of elevated mood, reduced sleep need, and behavioral changes to avoid misdiagnosis. [1] Cognitive impairment, including difficulties with attention, processing speed, and verbal learning, is also a notable feature of bipolar disorder that persists even during stable periods. [3]

Diagnosing Bipolar Disorder

There is no laboratory test, brain scan, or biomarker that can diagnose bipolar disorder. Diagnosis is entirely clinical and requires a comprehensive psychiatric evaluation based on DSM-5 criteria. The core distinctions between the primary bipolar subtypes are:

  • Bipolar I Disorder: At least one manic episode is required, lasting a minimum of one week or resulting in hospitalization. Depressive episodes frequently occur but are not required for diagnosis. [1]
  • Bipolar II Disorder: Requires at least one hypomanic episode (minimum 4 days) and at least one major depressive episode. No full manic episodes have occurred. Bipolar II is not a milder version of bipolar I; it often involves more time spent in depression and is frequently more difficult to recognize. [1]
  • Cyclothymic Disorder: Hypomanic and depressive symptoms that do not meet full episode criteria, persisting for at least two years. [1]

A thorough clinical assessment typically includes:

  • A complete psychiatric history, including a careful review of prior mood episodes (particularly past hypomanic or manic periods that may have been overlooked)
  • Mental status examination and standardized mood rating instruments
  • Medical and laboratory evaluation to rule out thyroid conditions, substance-induced mood states, neurological conditions, and other medical contributors [1]
  • Assessment for co-occurring conditions, including anxiety disorders, substance use disorders, ADHD, and personality disorders, which are common in bipolar disorder and affect treatment planning [3]
  • Collateral information from family members, who may have observed mood episodes the patient does not recall or recognize [1]

Accurate diagnosis is essential because bipolar disorder responds to a specific category of treatments, particularly mood stabilizers, that differ substantially from those used for unipolar depression. Misdiagnosing bipolar disorder as major depressive disorder and prescribing antidepressants without mood stabilization can trigger or worsen manic episodes. [1, 2]

At Amber Behavioral Health, our multidisciplinary clinical team, including board-certified psychiatrists, licensed therapists, and experienced nurse practitioners, conducts individualized assessments in a setting designed to feel safe and supportive. We understand the complexity of bipolar disorder and the toll a delayed or incorrect diagnosis can take. Our intake process is thorough, compassionate, and built around the individual.

Bipolar Disorder Treatment Options at Amber Behavioral Health

Bipolar disorder is a lifelong condition, but with the right combination of treatments, most people achieve meaningful symptom control and functional stability. Research consistently demonstrates that combined pharmacotherapy and psychotherapy produces better outcomes than medication alone. [10, 11]

Amber Behavioral Health offers several evidence-based treatments well-suited to the complex and chronic nature of bipolar disorder. Our clinical team works with each individual to develop a personalized treatment plan that addresses the full spectrum of their experience.

Medication Management:

  • Mood stabilizers are the pharmacological foundation of bipolar treatment. Lithium has the strongest evidence base, including significant anti-suicidal effects. Other mood stabilizers including valproate and lamotrigine are also well-supported. [1, 2]
  • Atypical antipsychotics, including quetiapine, olanzapine, and aripiprazole, are FDA-approved for various phases of bipolar disorder, including acute mania, bipolar depression, and maintenance. [2]
  • Antidepressants are used with caution and typically only in combination with a mood stabilizer, as they can induce manic switching or destabilize the mood cycle when used alone. [1]
  • All medication decisions at Amber are made and monitored by our board-certified psychiatric team, with regular reassessment and careful attention to tolerability, adherence, and individual response.

 

Evidence-Based Psychotherapies:

  • Cognitive Behavioral Therapy (CBT): A meta-analysis of randomized controlled trials found CBT to be an effective adjunct to medication, producing improvements in depressive symptoms, mania severity, relapse rates, and psychosocial functioning. [10] CBT is recommended by international clinical guidelines for all phases of bipolar disorder except acute mania. [11]
  • Family-Focused Therapy (FFT): Across eight randomized controlled trials, FFT combined with pharmacotherapy has consistently produced faster episode recovery, fewer relapses, and lower symptom severity over one to two years compared to briefer psychoeducational approaches. Patients receiving intensive psychotherapy are approximately 1.6 times more likely to be clinically well in any given month. [12]
  • Interpersonal and Social Rhythm Therapy (IPSRT): IPSRT targets the stabilization of daily social rhythms such as sleep, meals, and activity levels. Research shows that IPSRT during the acute phase is associated with longer periods without new episodes and is particularly relevant for bipolar I disorder. [10]
  • Psychoeducation: Psychoeducation is the most widely recommended and studied psychosocial intervention for bipolar disorder. It helps individuals and families understand the nature of the disorder, recognize early warning signs, improve medication adherence, and develop personalized relapse prevention plans. [10, 11]
  • Individual, Group, and Family Therapy: Sessions at each level address the personal, relational, and systemic consequences of bipolar disorder on the individual’s life and relationships.

 

Structured lifestyle supports, including consistent sleep schedules, stress reduction practices, and avoidance of substance use, are documented components of bipolar management and are incorporated into care where clinically appropriate. Amber Behavioral Health offers many such supports as part of a whole-person approach to treatment. To learn which specific treatment options may be most appropriate for your situation, please connect with our admissions team.

Living with Bipolar Disorder

Living well with bipolar disorder is possible. Many people with the condition maintain careers, relationships, and fulfilling lives with the right combination of treatment and self-management strategies. However, bipolar disorder is a chronic condition that requires ongoing attention rather than a one-time intervention. [2, 4]

Relapse prevention is central to long-term management. Research shows that medication adherence is one of the strongest predictors of stability; between 20% and 50% of individuals with bipolar disorder struggle with adherence, and psychotherapy can meaningfully improve this. [11] Developing a personalized relapse plan with a clinician, including identification of personal early warning signs for both manic and depressive episodes, gives individuals a structured response before a full episode escalates.

Research-supported strategies for long-term management include: [2, 10, 13]

  • Maintaining a consistent sleep and wake schedule: disrupted sleep is one of the most reliable triggers for mood episodes, particularly mania
  • Tracking mood daily using a mood chart or app to identify patterns, early warning signs, and the influence of specific stressors or behaviors
  • Continuing psychiatric and therapeutic follow-up even during stable periods; stability is not a reason to discontinue care
  • Taking prescribed medications consistently, even when feeling well; stopping medication is among the most common precipitants of relapse
  • Avoiding alcohol and recreational substances, which can destabilize mood, worsen symptoms, and interact with psychiatric medications
  • Building and maintaining a strong support network: family involvement and peer connection are protective factors for long-term stability
  • Establishing a written crisis plan in collaboration with a treatment team, outlining steps to take if symptoms escalate and trusted contacts to involve

 

Bipolar disorder carries a significantly elevated suicide risk, particularly during depressive and mixed episodes. [1] If you or someone you care about is experiencing suicidal thoughts, please seek help immediately or contact the 988 Suicide and Crisis Lifeline by calling or texting 988.

Why Choose Amber Behavioral Health?

Bipolar disorder demands a level of clinical precision that many treatment settings are simply not equipped to provide. Accurate diagnosis, carefully managed medication, and sustained therapeutic engagement all require a highly credentialed, collaborative team that truly knows the individual in their care. At Amber Behavioral Health, that is exactly what we offer.

Our small, home-like residential setting allows for the kind of individualized, relationship-based care that makes a measurable difference in bipolar treatment outcomes. Intentionally small caseloads mean each person receives genuine one-on-one therapeutic attention. Our board-certified psychiatrists, licensed clinical therapists, and experienced nursing staff collaborate closely to manage both the acute and long-term dimensions of the disorder.

We are particularly committed to family involvement in the treatment process. Research on family-focused therapy consistently shows that involving loved ones in care leads to faster recovery, fewer relapses, and better long-term outcomes. [12] At Amber, family is not a bystander to treatment; family is part of it. Our continuum of care, extending into step-down programming at our sister facility, Ignite Recovery Center, ensures that the foundation built during residential treatment continues to hold. If you are ready to take the first step, our admissions team is here to help.

Your Bipolar Disorder Questions Answered

Manic Depression FAQs

The defining distinction is the presence or absence of full mania. Bipolar I disorder requires at least one manic episode lasting a minimum of one week or resulting in hospitalization. Manic episodes in bipolar I are severe enough to cause marked impairment in functioning and may involve psychotic features. Bipolar II disorder, by contrast, involves hypomanic episodes rather than full mania. Hypomania is a less severe elevation of mood and energy that lasts at least four days and is noticeable to others but does not cause the level of impairment or require hospitalization. [1] Bipolar II also requires at least one major depressive episode. Contrary to a common misconception, bipolar II is not a milder form of bipolar I. People with bipolar II often spend significantly more time depressed and face different treatment challenges, including higher rates of misdiagnosis as unipolar depression.

Yes, bipolar disorder has a very strong genetic component. Twin studies estimate its heritability at 60% to 85%, meaning genetic factors account for a substantial proportion of risk. [5, 6] Having a first-degree relative, such as a parent or sibling, with bipolar disorder increases an individual's risk approximately tenfold compared to the general population. [4] That said, genetics is not destiny: not everyone with a family history of bipolar disorder will develop it. Environmental factors, including trauma, substance use, stress, and sleep disruption, interact with genetic predispositions to influence when and whether the disorder emerges. The disorder is polygenic, meaning many genes each contribute a small amount of risk rather than a single "bipolar gene" being responsible.

Bipolar disorder and borderline personality disorder (BPD) are frequently confused because both involve significant mood instability. However, they are distinct conditions with different patterns, causes, and treatments. In bipolar disorder, mood episodes are discrete periods of mania or depression that last days to weeks or months, often occur without an obvious external trigger, and are accompanied by characteristic changes in sleep, energy, speech, and thinking. [13, 14] In BPD, emotional swings tend to be more rapid, often shifting within minutes to hours in direct response to interpersonal stressors. BPD is also characterized by a chronically unstable sense of self, intense fear of abandonment, and a persistent pattern of unstable relationships, features that are not core to bipolar disorder. Bipolar disorder is generally more responsive to mood stabilizers and pharmacotherapy; BPD is primarily treated through specialized psychotherapy such as DBT. Approximately 20% of people with bipolar disorder also carry a BPD diagnosis, and this comorbidity significantly complicates both diagnosis and treatment. [14] Accurate differential diagnosis requires comprehensive clinical evaluation.

There is no single laboratory test, genetic test, or brain imaging study that can diagnose bipolar disorder. Diagnosis is based entirely on a comprehensive clinical evaluation that examines symptom history, pattern, and severity according to DSM-5 criteria. [1, 2] A clinician will typically review a complete psychiatric and medical history, conduct a mental status examination, administer standardized rating scales, perform laboratory work to rule out medical contributors (such as thyroid dysfunction), and gather collateral information from family members where possible. The process is thorough by necessity, as bipolar disorder shares surface features with several other conditions and misdiagnosis carries significant clinical consequences.

Bipolar disorder is coded under the F31 category in both ICD-10 and ICD-11. Specific codes vary by episode type and severity: F31.0 covers bipolar disorder with current hypomanic episode; F31.1x covers bipolar disorder with current manic episode without psychosis; F31.2 covers bipolar disorder with current manic episode with psychosis; F31.3x covers bipolar disorder with current mild or moderate depressive episode; F31.4 covers bipolar disorder with current severe depressive episode without psychosis; and F31.5 covers bipolar disorder with current severe depressive episode with psychosis, among others. [1] In clinical practice, the specific code used will depend on the current episode and presentation. Your treating clinician or psychiatric team will assign the applicable diagnostic code based on your individual clinical picture.

Pharmacotherapy, particularly mood stabilizers, remains the cornerstone of bipolar disorder treatment. The evidence base for medication, especially lithium, in preventing recurrence and reducing suicide risk is substantial and well-established. [1, 2] However, medication alone is rarely sufficient for full and lasting recovery. Psychotherapy, particularly CBT, family-focused therapy, and IPSRT, has strong evidence for improving outcomes when used alongside medication. [10] For most individuals with bipolar disorder, the goal is not to find an alternative to medication but to find the most effective and tolerable combination of pharmacological and psychosocial treatments. Any decision to reduce or discontinue medication should always be made collaboratively with a qualified psychiatric provider, as stopping medication is one of the most common precipitants of relapse.

Bipolar disorder is a lifelong condition, and the treatment approach reflects that reality. Most clinical guidelines recommend indefinite maintenance treatment, at minimum with medication management and regular psychiatric follow-up, because the risk of relapse without ongoing care is high. [1, 2] Initial stabilization of an acute mood episode may take weeks to months. Residential or inpatient levels of care are appropriate when symptoms are severe enough to impair safety or daily functioning. Following stabilization, step-down to partial hospitalization, intensive outpatient, or outpatient treatment continues the work of building the long-term skills and supports needed for sustained stability. The frequency and intensity of psychotherapy typically adjusts over time based on clinical status, but complete disengagement from care is generally not advisable.

Early warning signs vary from person to person, which is why mood monitoring and personalized relapse planning are central to long-term bipolar management. That said, certain patterns emerge frequently across individuals. Common early signs of an emerging manic or hypomanic episode include sleeping less without feeling fatigued, a notable increase in energy or talkativeness, racing or speeding thoughts, elevated or irritable mood, a sense of special purpose or grandiosity, and increased impulsive behavior. [2, 4] Early signs of a depressive episode often include increasing fatigue or low motivation, withdrawal from social activities, difficulty concentrating, changes in sleep or appetite, and a growing sense of hopelessness. [2] Recognizing these patterns early, and having a written plan that details what steps to take when they appear, is one of the most effective relapse prevention strategies available. Developing that plan is a central component of bipolar-focused psychotherapy.

Bipolar disorder can have a profound impact on relationships, work, and overall functioning, particularly when it is undiagnosed or inadequately treated. During manic episodes, impulsive behavior, irritability, and poor judgment can damage relationships and lead to financial, legal, or occupational consequences. During depressive episodes, withdrawal, low energy, and poor concentration can make it difficult to maintain employment or fulfill personal commitments. [2, 3] Even in euthymia, cognitive difficulties and the residual effects of past episodes can affect day-to-day functioning. Family members and partners are often deeply affected by the unpredictability of mood episodes. This is precisely why family-focused therapy and psychoeducation for loved ones are important components of comprehensive bipolar care. With sustained treatment and support, many individuals with bipolar disorder maintain stable, meaningful relationships and productive professional lives.

Sources

[1] Jain, A., & Mitra, P. (2023, February 20). Bipolar disorder. StatPearls. National Institutes of Health / NCBI Bookshelf. https://www.ncbi.nlm.nih.gov/books/NBK558998/

[2] American Psychiatric Association. (2022). Bipolar I and bipolar II disorders. DSM-5-TR. APA Publishing. https://www.psychiatry.org/getmedia/98fd2c17-93f0-42cd-9f41-755d77b862a5/APA-DSM5TR-BipolarIandBipolarIIDisorders.pdf

[3] Vieta, E., et al. (2025). Bipolar disorders: An update on critical aspects. PMC11732062. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC11732062/

[4] Harrison, P. J., Geddes, J. R., & Tunbridge, E. M. (2018). The emerging neurobiology of bipolar disorder. Trends in Neurosciences, 41(1). PMC5755726. https://pmc.ncbi.nlm.nih.gov/articles/PMC5755726/

[5] Gordovez, F. J. A., & McMahon, F. J. (2020). Genetic contributions to bipolar disorder: Current status and future directions. PMC8477227. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC8477227/

[6] Paris Brain Institute. (2025). Is bipolar disorder hereditary? https://parisbraininstitute.org/disease-files/bipolar-disorder/bipolar-disorder-hereditary

[7] Scaini, G., et al. (2020). Neurobiology of bipolar disorders: A review of genetic components, signaling pathways, biochemical changes, and neuroimaging findings. PMC7524405. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC7524405/

[8] Rowland, T. A., & Marwaha, S. (2018). Epidemiology and risk factors for bipolar disorder. PMC6116765. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC6116765/

[9] Aas, M., et al. (2020). Environmental factors, life events, and trauma in the course of bipolar disorder. PMC7167807. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC7167807/

[10] Miklowitz, D. J., & Chung, B. (2020). Evidence-based psychotherapies for bipolar disorder. PMC6999214. Focus: The Journal of Lifelong Learning in Psychiatry. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC6999214/

[11] Ozerdem, A., & Gitlin, M. (2021). Cognitive behavioral therapy in treatment of bipolar disorder. PMC8498810. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC8498810/

[12] Miklowitz, D. J. (2018). Family-focused therapy for bipolar disorder: Reflections on 30 years of research. PMC5922774. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC5922774/

[13] Cleveland Clinic. (2025). Borderline personality disorder vs. bipolar disorder. https://health.clevelandclinic.org/bpd-vs-bipolar

[14] Fornaro, M., et al. (2023). Bipolar disorder and borderline personality disorder: A diagnostic challenge. PMC10661435. National Institutes of Health. https://pmc.ncbi.nlm.nih.gov/articles/PMC10661435/